Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
31
pubmed:dateCreated
2006-10-31
pubmed:abstractText
To develop a gene expression-based classifier for neuroblastoma patients that reliably predicts courses of the disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5070-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:17075126-Disease-Free Survival, pubmed-meshheading:17075126-Gene Expression Profiling, pubmed-meshheading:17075126-Gene Expression Regulation, Neoplastic, pubmed-meshheading:17075126-Germany, pubmed-meshheading:17075126-Humans, pubmed-meshheading:17075126-Japan, pubmed-meshheading:17075126-Multivariate Analysis, pubmed-meshheading:17075126-Neuroblastoma, pubmed-meshheading:17075126-Odds Ratio, pubmed-meshheading:17075126-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:17075126-Predictive Value of Tests, pubmed-meshheading:17075126-Proportional Hazards Models, pubmed-meshheading:17075126-Reproducibility of Results, pubmed-meshheading:17075126-Risk Assessment, pubmed-meshheading:17075126-Survival Analysis, pubmed-meshheading:17075126-Tumor Markers, Biological, pubmed-meshheading:17075126-United States
pubmed:year
2006
pubmed:articleTitle
Customized oligonucleotide microarray gene expression-based classification of neuroblastoma patients outperforms current clinical risk stratification.
pubmed:affiliation
Children's Hospital, Department of Pediatric Oncology and Hematology, University of Cologne, Kerpener Strasse 62, D-50924 Cologne, Germany. andre.oberthuer@uk-koeln.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't